Vanda Pharmaceuticals Inc. (VNDA) SEC Filings — 2025
17 SEC filings for Vanda Pharmaceuticals Inc. (VNDA) in 2025.
Filings
- Vanda Pharmaceuticals Files 8-K — 8-K · Dec 31, 2025
- Vanda Pharmaceuticals Inc. 8-K Filing — 8-K · Dec 4, 2025
- Vanda Pharmaceuticals Inc. 8-K Filing — 8-K · Nov 28, 2025
- Vanda's Q3 Sales Up, But Soaring Costs Drive 324% Net Loss Increase — 10-Q · Oct 30, 2025
- Vanda Pharmaceuticals Files 8-K on Financials — 8-K · Oct 29, 2025
- Vanda Pharmaceuticals Files 8-K — 8-K · Oct 1, 2025
- Vanda Pharma Q2 Loss Widens on Fanapt Sales Dip — 10-Q · Jul 31, 2025
- Vanda Pharmaceuticals Files 8-K on Shareholder Votes — 8-K · Jun 5, 2025
- Vanda Pharma Files Proxy Supplement — DEFA14A · May 27, 2025
- Vanda Pharmaceuticals Files Q1 2025 10-Q — 10-Q · May 8, 2025
- Vanda Pharmaceuticals Files 8-K on Financials — 8-K · May 7, 2025
- Vanda Pharma Files 2025 Proxy Statement on Executive Pay — DEF 14A · Apr 25, 2025
- Vanda Pharmaceuticals Files 8-K for Regulation FD Disclosure — 8-K · Mar 17, 2025
- Vanda Pharmaceuticals Reports Director/Officer Changes — 8-K · Feb 20, 2025
- Vanda Pharmaceuticals Files 2024 10-K — 10-K · Feb 14, 2025
- Vanda Pharmaceuticals Files 8-K on Financials — 8-K · Feb 13, 2025
- Vanda Pharmaceuticals Files 8-K: Regulation FD Disclosure — 8-K · Jan 27, 2025